Sun Pharma turns volatile after announcing Q1 results

Sun Pharmaceutical Industries was up 0.01% to Rs 808.95 at 14:46 IST on BSE after consolidated net profit surged 265.84% to Rs 2033.71 crore on 21.29% growth in total income to Rs 8400.09 crore in Q1 June 2016 over Q1 June 2015.

The result was announced during market hours today, 12 August 2016.

Meanwhile, the S&P BSE Sensex was up 316.88 points or 1.14% at 28,176.48.

On BSE, so far 8.14 lakh shares were traded in the counter as against average daily volume of 2.92 lakh shares in the past one quarter. The stock was volatile. The stock rose as much as 2.07% at the day's high of Rs 825.70 so far during the day. The stock lost as much as 2.08% at the day's low of Rs 792 so far during the day. The stock had hit a 52-week high of Rs 965.15 on 20 August 2015. The stock had hit a 52-week low of Rs 706.40 on 24 November 2015. The stock had outperformed the market over the past one month till 11 August 2016, advancing 2.45% compared with 0.84% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, gaining 1.61% as against Sensex's 8.84% rise.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Rs 1.

Sun Pharmaceutical Industries' (Sun Pharma) bottom line in Q1 June 2016 was boosted due to base effect. The company's bottom line in Q1 June 2015 was adversely impacted by exceptional expense of Rs 685.17 crore.

Sun Pharmaceutical Industries is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Powered by Capital Market - Live News